Compare · STEX vs TMDX
STEX vs TMDX
Side-by-side comparison of Streamex Corp. (STEX) and TransMedics Group Inc. (TMDX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both STEX and TMDX operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- TMDX is the larger of the two at $2.53B, about 26.0x STEX ($97.3M).
- Over the past year, STEX is down 85.2% and TMDX is down 41.0% - TMDX leads by 44.2 points.
- STEX has been more active in the news (9 items in the past 4 weeks vs 3 for TMDX).
- TMDX has more recent analyst coverage (18 ratings vs 1 for STEX).
- Company
- Streamex Corp.
- TransMedics Group Inc.
- Price
- $0.93-8.97%
- $73.17-3.27%
- Market cap
- $97.3M
- $2.53B
- 1M return
- -6.16%
- +6.91%
- 1Y return
- -85.19%
- -41.00%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- News (4w)
- 9
- 3
- Recent ratings
- 1
- 18
TransMedics Group Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.
Latest STEX
- Interim Executive Chairman Lekstrom Morgan Lee bought $49,750 worth of shares (50,000 units at $0.99) (SEC Form 4)
- Chief Investment Officer Williams Mitchell Young sold $24,915 worth of shares (23,810 units at $1.05), decreasing direct ownership by 0.78% to 3,013,838 units (SEC Form 4) to satisfy withholding obligation
- Amendment: SEC Form 4 filed by Interim Executive Chairman Lekstrom Morgan Lee
- Amendment: Interim Executive Chairman Lekstrom Morgan Lee bought $147,289 worth of shares (47,000 units at $3.13) (SEC Form 4)
- Streamex Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Interim Executive Chairman Lekstrom Morgan Lee bought $49,980 worth of shares (34,000 units at $1.47) (SEC Form 4)
- Streamex Corp. and Orca Announce Launch of 24/7 Decentralized Secondary Liquidity Infrastructure for Tokenized Securities; GLDY the Inaugural Asset
- Streamex Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Streamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and Design
- Director Marciano Anthony Mark bought $20,052 worth of shares (17,745 units at $1.13), increasing direct ownership by 18% to 117,745 units (SEC Form 4)
Latest TMDX
- Director Gunderson Thomas J. exercised 19,285 shares at a strike of $2.21 and sold $722,377 worth of shares (9,624 units at $75.06), increasing direct ownership by 138% to 16,642 units (SEC Form 4) (for withholding tax)
- SEC Form 144 filed by TransMedics Group Inc.
- SEC Form SD filed by TransMedics Group Inc.
- Director Basile Edward M was granted 2,922 shares, increasing direct ownership by 102% to 5,788 units (SEC Form 4)
- Director Gunderson Thomas J. was granted 2,922 shares, increasing direct ownership by 72% to 6,981 units (SEC Form 4)
- Director Raines Merilee was granted 2,922 shares, increasing direct ownership by 72% to 6,981 units (SEC Form 4)
- Director Weill David was granted 2,922 shares, increasing direct ownership by 24% to 15,056 units (SEC Form 4)
- Director Lovell Stephanie was granted 2,922 shares, increasing direct ownership by 102% to 5,788 units (SEC Form 4)
- Director Tobin James R was granted 2,922 shares, increasing direct ownership by 72% to 6,981 units (SEC Form 4)
- Director Kania Edwin was granted 2,922 shares, increasing direct ownership by 1% to 263,732 units (SEC Form 4)